Memantine in Patients With Chronic Glaucoma
Phase 3
Completed
- Conditions
- Open-Angle Glaucoma
- Registration Number
- NCT00168350
- Lead Sponsor
- Allergan
- Brief Summary
Randomized double-masked clinical trial of memantine in patients with glaucoma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1179
Inclusion Criteria
- glaucoma damage on examination of visual field and optic disc
- good visual acuity (with glasses if needed)
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Progression of glaucoma
- Secondary Outcome Measures
Name Time Method